furylfuramide has been researched along with tamoxifen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bouvier, M; Diennet, M; El Ezzy, M; Haidar, S; Mader, S; Vallet, A | 1 |
1 other study(ies) available for furylfuramide and tamoxifen
Article | Year |
---|---|
The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fulvestrant; Furylfuramide; Humans; Ligands; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Sumoylation; Tamoxifen | 2023 |